SCHEMBL20105148

SCHEMBL20105148

CC(Nc1cc2c(cc1N)C(C)(C)C(=O)N2C(C)C)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.39
SLC6A2 P23975 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MARK3 P27448 2/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2B6 P20813 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
ADAMTS5 Q9UNA0 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
NUDT1 P36639 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ASPH Q12797 1/20 0.34
RIOX2 Q8IUF8 1/20 0.34
KDM8 Q8N371 1/20 0.34
IDH1 O75874 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LDHA P00338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17254682 1.00 SLC6A4 (0.39) SLC6A4SLC6A2MEN1KMT2AMARK3
SCHEMBL17254694 0.87 HTT (0.38) SLC6A4SLC6A2MEN1KMT2ACYP3A4
SCHEMBL20105192 0.87 HTT (0.38) SLC6A4SLC6A2MEN1KMT2ACYP3A4
SCHEMBL17254680 0.86 MEN1 (0.38) SLC6A4SLC6A2MEN1KMT2ACYP3A4
SCHEMBL20105231 0.86 MEN1 (0.38) SLC6A4SLC6A2MEN1KMT2ACYP3A4
SCHEMBL21217885 0.86 SLC6A4 (0.41) SLC6A4SLC6A2MEN1KMT2AMARK3
SCHEMBL20105186 0.84 BRD4 (0.42) SLC6A4SLC6A2MEN1KMT2AMARK3
SCHEMBL17254695 0.84 BRD4 (0.42) SLC6A4SLC6A2MEN1KMT2AMARK3
SCHEMBL17254668 0.82 CRHBP (0.55) KMT2ACRHBPCRHR2SMN1; SMN2HTT
SCHEMBL16707142 0.77 BRD4 (0.40) SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019145410-A1 COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-01 WO disclosed
EP-3140304-B1 BENZIMIDAZOLE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2018-05-02 EP disclosed